1. Comparative in vitro study on the local tolerance and efficacy of benzalkonium chloride, myristalkonium chloride and nonoxynol-9 as active principles in vaginal contraceptives.
- Author
-
Alfaiate MI, António Santos R, Silva AF, Sousa AP, Almeida-Santos T, Gendron C, Jabbour V, Mas Y, Verriere F, Ramalho-Santos J, and Tavares RS
- Subjects
- Chlorides, Female, HeLa Cells drug effects, Humans, Male, Benzalkonium Compounds pharmacology, Contraceptive Agents pharmacology, Nonoxynol pharmacology, Spermatocidal Agents pharmacology, Spermatozoa drug effects
- Abstract
Background: Spermicides have been identified as a potentially attractive alternative to hormonal contraceptives and/or intrauterine devices. Thus, this study aimed evaluating the efficacy and local tolerance of benzalkonium chloride (BKC) and myristalkonium chloride (MKC) contained in Pharmatex
® vaginal formulations and compare them with nonoxynol-9 (N-9), the most common active ingredient in topical vaginal contraceptives., Methods: Human normozoospermic samples were assessed for motility, viability, acrosome status and penetration ability after exposure to control, N-9 or different BKC and MKC doses for 0 and 10 minutes. Local tolerance on HeLa cells was evaluated by the Trypan-blue and MTT assays., Results: Exposure to BKC and MKC reduced acrosome integrity while promoting total immobilisation and complete loss of sperm viability ( p < .001, n = 15). Both compounds also compromised sperm penetration ability upon exposure ( p < .001, n = 15). N-9 induced the same outcomes ( p < .001, n = 15); nevertheless, it was more toxic to HeLa cells than BKC and MKC ( p < .05, n = 14)., Conclusions: BKC and MKC present strong in vitro spermicidal activity at lower doses than N-9 and were better tolerated after immediate exposure than N-9. Available Pharmatex® galenic formulations were as effective as products based on N-9.- Published
- 2021
- Full Text
- View/download PDF